HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Mir, S. Articles by Taylor, D. Search for Related Content PubMed Articles by Mir, S. Articles by Taylor, D.

Sexual adverse effects with new antidepressants

Maudsley Hospital, Denmark Hill, London SE5 8AZ

^* Correspondence

Sexual dysfunction is a widely recognised adverse effect of many psychotropic agents. Older antidepressants such as monoamine oxidase inhibitors and tricyclics, particularly clomipramine, are known to engender sexual adverse effects. In depression, this problem is exacerbated by the occurrence of impotence and lowered libido as part of depressive illness itself. We examined evidence relating to more recently introduced antidepressants: selective serotonin reuptake inhibitors, moclobemide, venlafaxine, nefazodone, mirtazapine and reboxetine. We reviewed published trials and case reports collated from searches of Medline, Psychlit and Micromedex from 1985 to December 1997, and contacted manufacturers of new antidepressants and requested information from them.

This article has been cited by other articles:

				D. S Baldwin Depression and sexual dysfunction Br. Med. Bull., March 1, 2001; 57(1): 81 - 99. [Abstract] [Full Text] [PDF]